Primary |
Drug Use For Unknown Indication |
20.3% |
Product Used For Unknown Indication |
14.5% |
Asthma |
14.1% |
Rhinitis Allergic |
12.3% |
Rhinitis |
5.7% |
Bronchitis |
4.4% |
Hiv Infection |
4.4% |
Sinusitis |
4.0% |
Adenoiditis |
3.1% |
Nasal Congestion |
2.2% |
Nasal Polyps |
2.2% |
Glaucoma |
1.8% |
Hypertension |
1.8% |
Superinfection |
1.8% |
Chronic Sinusitis |
1.3% |
Hypersensitivity |
1.3% |
Pain |
1.3% |
Prophylaxis Of Neural Tube Defect |
1.3% |
Seasonal Allergy |
1.3% |
Arthritis |
0.9% |
|
Anosmia |
21.1% |
Asthma |
8.4% |
Off Label Use |
7.4% |
Product Quality Issue |
7.4% |
Dyspnoea |
6.3% |
Visual Acuity Reduced |
5.3% |
Encephalitis |
4.2% |
Ocular Hypertension |
4.2% |
Urticaria |
4.2% |
Dizziness |
3.2% |
Skin Striae |
3.2% |
Swelling Face |
3.2% |
Syncope |
3.2% |
Throat Tightness |
3.2% |
Tremor |
3.2% |
Vision Blurred |
3.2% |
Weight Decreased |
3.2% |
Aggression |
2.1% |
Candida Infection |
2.1% |
Extrasystoles |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
33.3% |
Asthma |
26.7% |
Bronchitis |
16.7% |
Drug Use For Unknown Indication |
6.7% |
Arthritis |
3.3% |
Conjunctivitis |
3.3% |
Hypercholesterolaemia |
3.3% |
Rhinitis |
3.3% |
Sinusitis |
3.3% |
|
Death |
13.3% |
Product Quality Issue |
13.3% |
Anosmia |
6.7% |
Asthma |
6.7% |
Asthmatic Crisis |
6.7% |
Dizziness |
6.7% |
Dysgeusia |
6.7% |
Pancreatitis |
6.7% |
Respiratory Failure |
6.7% |
Tooth Erosion |
6.7% |
Visual Impairment |
6.7% |
Weight Decreased |
6.7% |
Weight Increased |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
39.4% |
Asthma |
11.8% |
Depression |
10.3% |
Drug Use For Unknown Indication |
4.9% |
Anxiety |
4.7% |
Hypertension |
3.4% |
Rhinitis Allergic |
3.4% |
Hypersensitivity |
3.0% |
Multiple Sclerosis |
2.7% |
Chronic Obstructive Pulmonary Disease |
2.5% |
Rheumatoid Arthritis |
2.5% |
Colitis Ulcerative |
2.0% |
Coronary Artery Disease |
1.7% |
Non-small Cell Lung Cancer |
1.5% |
Primary Ciliary Dyskinesia |
1.5% |
Arthritis |
1.2% |
Bronchitis |
1.0% |
Sinusitis |
1.0% |
Analgesic Therapy |
0.7% |
Bronchiectasis |
0.7% |
|
Blood Immunoglobulin M Decreased |
11.3% |
Photopsia |
8.1% |
Sinusitis |
8.1% |
Suicidal Ideation |
8.1% |
Withdrawal Syndrome |
6.5% |
Basal Cell Carcinoma |
4.8% |
Dizziness |
4.8% |
Pyrexia |
4.8% |
Rash |
4.8% |
Trismus |
4.8% |
Urticaria |
4.8% |
Asthma |
3.2% |
Cardiac Arrest |
3.2% |
Cough |
3.2% |
Infection |
3.2% |
Normochromic Normocytic Anaemia |
3.2% |
Overdose |
3.2% |
Paraesthesia |
3.2% |
Rhinitis Allergic |
3.2% |
Serum Sickness |
3.2% |
|
Interacting |
Product Used For Unknown Indication |
68.4% |
Hiv Infection |
15.8% |
Asthmatic Crisis |
10.5% |
Rhinitis Allergic |
5.3% |
|
Hepatic Enzyme Increased |
50.0% |
Hypertension |
50.0% |
|